|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02607 SH PHARMA
Nominal 
11.570 +0.170 (+1.491%) Ranking Overview
Ranking based on 5 research report(s)
Average Ranking 2.00
|
Strong Buy (1)
0
|
Buy (2)
5
|
Hold (3)
0
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2025 | EPS | 154.00 RMB (cts) | |
| Net Profit | 5,724.56 RMB (MIL) | DPS | 47.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2026 | 5,296.00 | 143.00 | 43.00 | -- | 6,016.00 | 4,806.00 |
| 2027 | 5,401.00 | 146.00 | 44.00 | -- | 6,387.00 | 5,038.00 |
| 2028 | 5,919.50 | 159.90 | 48.35 | -- | 6,913.00 | 5,261.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2026 | 5,838.00 | 157.00 | 50.00 | CLSA | OutPerform | 16.70 | 31/08/2026 | |
| 2026 | 5,296.00 | 143.00 | 43.00 | UBS | Buy | 15.30 | 31/08/2026 | |
| 2026 | 6,016.00 | 162.00 | 49.00 | CICC | Outperform | 14.70 | 30/04/2026 | |
| 2026 | 4,806.00 | 130.00 | 39.50 | BANK OF AMERICA | Buy | 14.00 | 02/04/2026 | |
| 2026 | 4,956.00 | 133.90 | 40.10 | CITIGROUP | Buy | 13.50 | 13/04/2026 | |
| 2027 | 6,057.00 | 163.00 | 50.00 | CLSA | -- | -- | 31/08/2026 | |
| 2027 | 5,401.00 | 146.00 | 44.00 | UBS | -- | -- | 31/08/2026 | |
| 2027 | 6,387.00 | 172.00 | 52.00 | CICC | -- | -- | 30/04/2026 | |
| 2027 | 5,038.00 | 136.00 | 41.40 | BANK OF AMERICA | -- | -- | 02/04/2026 | |
| 2027 | 5,394.00 | 145.70 | 43.60 | CITIGROUP | -- | -- | 13/04/2026 | |
| 2028 | 6,913.00 | 186.00 | 60.00 | CLSA | -- | -- | 31/08/2026 | |
| 2028 | 6,071.00 | 164.00 | 50.00 | UBS | -- | -- | 31/08/2026 | |
| 2028 | 5,261.00 | 142.00 | 43.20 | BANK OF AMERICA | -- | -- | 02/04/2026 | |
| 2028 | 5,768.00 | 155.80 | 46.70 | CITIGROUP | -- | -- | 13/04/2026 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 04/09/2026 17:59 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 5,724,558 |
| %Change | 25.745% |
| EPS / (LPS) | RMB 1.540 |
| NBV Per Share (¥) | RMB 20.465 |